FDA.reportPublic FDA data

Clearasil

Manufacturer
Reckitt Benckiser LLC
Effective date
2015-06-26
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:31:24

Label at a glance#

ProductClearasil Ultra Rapid Action Clear Skin
Active ingredientSalicylic Acid, Benzoyl Peroxide
Label structure27 sections

Dosage and administration

wet face dispense product into hands and massage gently onto face and neck, avoiding the delicate eye area cover the entire affected area with a thin layer and rinse thoroughly with warm water one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or pee...

Storage and handling

store in a cool, dry place do not freeze

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Rapid Action Daily Face Wash

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 2%

Purpose

OTC - PURPOSE SECTION

Acne medication

Use

INDICATIONS & USAGE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • limit use to the face and neck

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • wet face
  • dispense product into hands and massage gently onto face and neck, avoiding the delicate eye area
  • cover the entire affected area with a thin layer and rinse thoroughly with warm water one to three times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Other information

STORAGE AND HANDLING SECTION

  • store in a cool, dry place
  • do not freeze

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, sodium cocoyl isethionate, cetearyl alcohol, glycerin, sodium laureth sulfate, sodium cocoamphoacetate, cocamidopropyl betaine, sodium hydroxide, acrylates/C10-30 alkyl acrylate crosspolymer, fragrance, disodium EDTA, Lavandula stoechas extract, Helichrysum italicum extract, Cistus monspeliensis extract

SPL UNCLASSIFIED SECTION

Rapid Action Pads

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 2%

Purpose

OTC - PURPOSE SECTION

Acne medication

Use

INDICATIONS & USAGE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only

Flammable keep away from extreme heat or open flame

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes. If product gets into the eyes rinse thoroughly with water.
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • limit use to the face and neck

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • clean the skin thoroughly before applying this product
  • wipe a pad over face and neck to cover the entire affected area with a thin layer 1 to 3 times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Other information

STORAGE AND HANDLING SECTION

  • keep jar lid tightly closed
  • store in a cool, dry place but do not freeze

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, alcohol denat., glycerin, isoceteth-20, sorbitol, sodium hydroxide, fragrance, Lavandula stoechas extract, Helichrysum italicum extract, Cistus monspeliensis extract, disodium EDTA

SPL UNCLASSIFIED SECTION

Rapid Action Vanishing Treatment Cream

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzoyl Peroxide 10%

Purpose

OTC - PURPOSE SECTION

Acne medication

Use

INDICATIONS & USAGE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use if you have very sensitive skin or are sensitive to benzoyl peroxide

When using this product

OTC - WHEN USING SECTION

  • avoid unnecessary sun exposure and use a sunscreen
  • avoid contact with the eyes, lips and mouth
  • avoid contact with hair or dyed fabrics, including carpet and clothing which may be bleached by this product
  • with other topical acne medications, at the same time or immediately following use of this product, increased dryness or irritation of the skin may occur. If this occurs, only one medication should be used unless directed by a doctor.
  • skin irritation may occur, characterized by redness, burning, itching, peeling or possibly swelling. More frequent use or higher concentrations may aggravate skin irritation. Mild irritation may be reduced by using the product less frequently or in a lower concentration.

OTC - STOP USE SECTION

Stop use and ask a doctor if skin irritation becomes severe

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

  • cleanse the skin thoroughly before applying medication
  • cover the entire affected area with a thin layer one to three times daily
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
  • if going outside, use a sunscreen. Allow Clearasil Ultra® Rapid Action Vanishing Treatment Cream to dry, then follow directions on sunscreen labeling. If irritation or sensitivity develops, discontinue use of both products and ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • keep tightly closed
  • store at controlled room temperature 68-77°F (20-25°C)

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, gluconolactone, glyceryl stearate, glycerin, PEG-40 stearate, PEG-100 stearate, cetyl alcohol, dimethicone, magnesium aluminum silicate, xanthan gum, phenoxyethanol, ammonium hydroxide, isopropylparaben, butylparaben, isobutylparaben, arginine, titanium dioxide

Questions?

OTC - QUESTIONS SECTION

call 1-866-25-CLEAR (1-866-252-5327).

You may also report side effects to this phone number.

SPL UNCLASSIFIED SECTION

Distributed by: Reckitt Benckiser LLC.
Parsippany, NJ 07054-0224

PRINCIPAL DISPLAY PANEL - Kit Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Clearasil®

ULTRA™

Rapid Action
Clear Skin Kit

MAXIMUM
STRENGTH

Visibly
clearer skin
in as little as
12 hours

  • Clearasil Ultra Rapid
    Action Daily Face Wash
    6.78 FL. OZ. (200 mL)
  • Clearasil Ultra Rapid
    Action Pads
    90 Pads 3.58 in2 (23.1 cm2)
  • Clearasil Ultra Rapid
    Action Treatment Cream
    0.45 OZ. (13 g)
PRINCIPAL DISPLAY PANEL - Kit Carton
PRINCIPAL DISPLAY PANEL - Kit Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63824-423-002023-10-20C16284748780-19d75b9cf-eed9-f424-e053-dadaa90a57ceClearasil ® Ultra™ Rapid Action Clear Skin
63824-423-002020-01-31C16284748780-19d75b9cf-eed9-f424-e053-dadaa90a57ceClearasil ® Ultra™ Rapid Action Clear Skin

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Benzoyl PeroxideACTIVE INGREDIENTW9WZN9A0GM1
Salicylic AcidACTIVE INGREDIENTO414PZ4LPZ1
Benzoyl PeroxideACTIVE MOIETYW9WZN9A0GM1
Salicylic AcidACTIVE MOIETYO414PZ4LPZ1
alcoholINACTIVE INGREDIENT3K9958V90M1
ammoniaINACTIVE INGREDIENT5138Q19F1X1
arginineINACTIVE INGREDIENT94ZLA3W45F1
butylparabenINACTIVE INGREDIENT3QPI1U3FV81
cetostearyl alcoholINACTIVE INGREDIENT2DMT128M1S1
cocamidopropyl betaineINACTIVE INGREDIENT5OCF3O11KX1
dimethiconeINACTIVE INGREDIENT92RU3N3Y1O1
edetate disodiumINACTIVE INGREDIENT7FLD91C86K1
gluconolactoneINACTIVE INGREDIENTWQ29KQ9POT1
glycerinINACTIVE INGREDIENTPDC6A3C0OX1
glyceryl monostearateINACTIVE INGREDIENT230OU9XXE41
Helichrysum italicum flowerINACTIVE INGREDIENTP62Y550X241
isobutylparabenINACTIVE INGREDIENT0QQJ25X58G1
isoceteth-20INACTIVE INGREDIENTO020065R7Z1
isopropylparabenINACTIVE INGREDIENTA6EOX47QK01
lavandula stoechas flowering topINACTIVE INGREDIENT70759G2U6A1
magnesium aluminum silicateINACTIVE INGREDIENT6M3P64V0NC1
PEG-100 stearateINACTIVE INGREDIENTYD01N1999R1
PEG-40 stearateINACTIVE INGREDIENTECU18C66Q71
phenoxyethanolINACTIVE INGREDIENTHIE492ZZ3T1
sodium cocoamphoacetateINACTIVE INGREDIENTW7Q5E876741
sodium cocoyl isethionateINACTIVE INGREDIENT518XTE84931
sodium hydroxideINACTIVE INGREDIENT55X04QC32I1
sodium laureth-3 sulfateINACTIVE INGREDIENTBPV390UAP01
sorbitolINACTIVE INGREDIENT506T60A25R1
titanium dioxideINACTIVE INGREDIENT15FIX9V2JP1
waterINACTIVE INGREDIENT059QF0KO0R1
xanthan gumINACTIVE INGREDIENTTTV12P4NEE1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 35 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
63824-42363824-423-00
63824-38063824-380-88
63824-34563824-345-01
63824-30963824-309-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 40 matching rows.

Name, UNII, Kind table
NameUNIIKind
Salicylic AcidO414PZ4LPZACTIB
water059QF0KO0RIACT
sodium cocoyl isethionate518XTE8493IACT
cetostearyl alcohol2DMT128M1SIACT
glycerinPDC6A3C0OXIACT
sodium laureth-3 sulfateBPV390UAP0IACT
sodium cocoamphoacetateW7Q5E87674IACT
cocamidopropyl betaine5OCF3O11KXIACT
sodium hydroxide55X04QC32IIACT
edetate disodium7FLD91C86KIACT
lavandula stoechas flowering top70759G2U6AIACT
helichrysum italicum flowerP62Y550X24IACT
Salicylic AcidO414PZ4LPZACTIB
water059QF0KO0RIACT
alcohol3K9958V90MIACT
glycerinPDC6A3C0OXIACT
isoceteth-20O020065R7ZIACT
sorbitol506T60A25RIACT
sodium hydroxide55X04QC32IIACT
lavandula stoechas flowering top70759G2U6AIACT
Helichrysum italicum flowerP62Y550X24IACT
edetate disodium7FLD91C86KIACT
Benzoyl PeroxideW9WZN9A0GMACTIB
water059QF0KO0RIACT
gluconolactoneWQ29KQ9POTIACT
glyceryl monostearate230OU9XXE4IACT
glycerinPDC6A3C0OXIACT
PEG-40 stearateECU18C66Q7IACT
PEG-100 stearateYD01N1999RIACT
cetostearyl alcohol2DMT128M1SIACT
dimethicone92RU3N3Y1OIACT
magnesium aluminum silicate6M3P64V0NCIACT
xanthan gumTTV12P4NEEIACT
phenoxyethanolHIE492ZZ3TIACT
ammonia5138Q19F1XIACT
isopropylparabenA6EOX47QK0IACT
butylparaben3QPI1U3FV8IACT
isobutylparaben0QQJ25X58GIACT
arginine94ZLA3W45FIACT
titanium dioxide15FIX9V2JPIACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 11 · 606 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
sodium hydroxideSODIUM HYDROXIDE55X04QC32IOINTMENT, AUGMENTED / TOPICAL0.11 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KSYRUP / ORAL40 mgExact identifier — unii candidate
77 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXCAPSULE, COATED / ORAL14.21 mgExact identifier — unii candidate
75 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / PARENTERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
alcoholALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii candidate
59 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXINJECTION / INTRAVENOUS33750 mgExact identifier — unii candidate
75 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
alcoholALCOHOL3K9958V90MPOWDER, FOR SOLUTION / TOPICAL40 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ammoniaAMMONIA SOLUTION5138Q19F1XCAPSULE / ORAL0.01 mgExact identifier — unii candidate
14 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ICAPSULE, COATED PELLETS / ORAL0.01 mgExact identifier — unii candidate
174 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSPRAY / SUBLINGUAL397 mgExact identifier — unii candidate
59 equally ranked IID candidates
sorbitolSORBITOL506T60A25RINJECTION / INTRA-ARTICULAR45 %w/vExact identifier — unii candidate
44 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KTABLET, ORALLY DISINTEGRATING / ORAL3 mgExact identifier — unii candidate
77 equally ranked IID candidates
xanthan gumXANTHAN GUMTTV12P4NEEPOWDER, FOR SOLUTION / ORAL10 mg/5mlExact identifier — unii candidate
29 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ISUSPENSION, EXTENDED RELEASE / INTRASYNOVIALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
arginineARGININE94ZLA3W45FPOWDER, FOR SOLUTION / INTRAVENOUS7.07 %w/vExact identifier — unii candidate
11 equally ranked IID candidates
gluconolactoneGLUCONOLACTONEWQ29KQ9POTSPONGE / TOPICALADJ PHExact identifier — unii candidate
6 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KSOLUTION / RESPIRATORY (INHALATION)43 mgExact identifier — unii candidate
77 equally ranked IID candidates
xanthan gumXANTHAN GUMTTV12P4NEELOZENGE / ORAL1264 mgExact identifier — unii candidate
29 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KINJECTION / INTRAVENOUS10 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL, METERED / NASAL70 mgExact identifier — unii candidate
59 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KPOWDER, FOR SUSPENSION / ORAL285 mgExact identifier — unii candidate
77 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION / IRRIGATIONADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
PEG-100 stearatePEG-100 MONOSTEARATEYD01N1999RLOTION / TOPICAL1 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSPRAY / TRANSDERMAL90 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
sorbitolSORBITOL506T60A25RPOWDER, FOR SUSPENSION / ORAL12000 mgExact identifier — unii candidate
44 equally ranked IID candidates
butylparabenBUTYLPARABEN3QPI1U3FV8SOLUTION / ORAL6 mgExact identifier — unii candidate
15 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ISOLUTION / AURICULAR (OTIC)0.8 %w/wExact identifier — unii candidate
174 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IPOWDER, FOR SOLUTION / ORALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXLOTION / TOPICAL3990 mgExact identifier — unii candidate
75 equally ranked IID candidates
ammoniaAMMONIA SOLUTION5138Q19F1XTABLET / ORALNAExact identifier — unii candidate
14 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / INTRATHECAL176 mgExact identifier — unii candidate
174 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ICAPSULE / ORAL60 mgExact identifier — unii candidate
174 equally ranked IID candidates
sorbitolSORBITOL506T60A25RTABLET, DELAYED RELEASE / ORAL0.01 mgExact identifier — unii candidate
44 equally ranked IID candidates
xanthan gumXANTHAN GUMTTV12P4NEESOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC0.6 %w/wExact identifier — unii candidate
29 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KSOLUTION/ DROPS / OPHTHALMIC0.13 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
alcoholALCOHOL3K9958V90MCONCENTRATE / BUCCAL679 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ammoniaAMMONIA SOLUTION5138Q19F1XINJECTION / INTRAVENOUS0.22 %w/vExact identifier — unii candidate
14 equally ranked IID candidates
gluconolactoneGLUCONOLACTONEWQ29KQ9POTINJECTION / INTRAMUSCULARADJ PHExact identifier — unii candidate
6 equally ranked IID candidates
xanthan gumXANTHAN GUMTTV12P4NEESUSPENSION/ DROPS / ORAL22 mgExact identifier — unii candidate
29 equally ranked IID candidates
sorbitolSORBITOL506T60A25RTABLET, EXTENDED RELEASE / ORAL428 mgExact identifier — unii candidate
44 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, SOLUTION / PARENTERALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION / PERINEURALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
ammoniaAMMONIA SOLUTION5138Q19F1XGEL / TOPICAL1.2 %w/wExact identifier — unii candidate
14 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSUSPENSION / AURICULAR (OTIC)0.05 %w/wExact identifier — unii candidate
75 equally ranked IID candidates
xanthan gumXANTHAN GUMTTV12P4NEETABLET / ORAL56 mgExact identifier — unii candidate
29 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KTABLET, FILM COATED / ORAL4 mgExact identifier — unii candidate
77 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ISUSPENSION / ORAL400 mgExact identifier — unii candidate
174 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SUSPENSION / INTRAVENOUSADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
gluconolactoneGLUCONOLACTONEWQ29KQ9POTINJECTION / INTRAVENOUSADJ PHExact identifier — unii candidate
6 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IINJECTION, POWDER, FOR SOLUTION / INTRADISCALADJ PHExact identifier — unii candidate
174 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32IMOUTHWASH / BUCCAL2 mg/1mlExact identifier — unii candidate
174 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPCAPSULE / RESPIRATORY (INHALATION)NAExact identifier — unii candidate
40 equally ranked IID candidates
sodium hydroxideSODIUM HYDROXIDE55X04QC32ITABLET, ORALLY DISINTEGRATING / ORAL1 mgExact identifier — unii candidate
174 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL, SPRAY / TOPICAL561 mgExact identifier — unii candidate
59 equally ranked IID candidates
titanium dioxideTITANIUM DIOXIDE15FIX9V2JPGUM, CHEWING / BUCCAL182 mgExact identifier — unii candidate
40 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KINJECTION, SOLUTION / INTRAVENOUS7 mgExact identifier — unii candidate
77 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXAEROSOL, FOAM / TOPICAL21 mgExact identifier — unii candidate
75 equally ranked IID candidates
edetate disodiumEDETATE DISODIUM7FLD91C86KCREAM, AUGMENTED / TOPICAL2 mgExact identifier — unii candidate
77 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
07eed0e5-357a-f3b6-e063-6294a90a899af98bd2da-82fd-4dce-ad6f-42f21aa015ee2023-10-17WarningsExact identifier
spl set id: f98bd2da-82fd-4dce-ad6f-42f21aa015ee

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.